NO861474L - Fremgangsmaate ved fremstilling av fenetanolaminderivater. - Google Patents

Fremgangsmaate ved fremstilling av fenetanolaminderivater.

Info

Publication number
NO861474L
NO861474L NO861474A NO861474A NO861474L NO 861474 L NO861474 L NO 861474L NO 861474 A NO861474 A NO 861474A NO 861474 A NO861474 A NO 861474A NO 861474 L NO861474 L NO 861474L
Authority
NO
Norway
Prior art keywords
procedure
preparation
phenetanolamine
derivatives
phenetanolamine derivatives
Prior art date
Application number
NO861474A
Other languages
English (en)
Other versions
NO164020C (no
NO164020B (no
Inventor
Leo Alig
Marcel Mueller
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO861474L publication Critical patent/NO861474L/no
Publication of NO164020B publication Critical patent/NO164020B/no
Publication of NO164020C publication Critical patent/NO164020C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/62Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO861474A 1985-04-16 1986-04-15 Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater. NO164020C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH160785 1985-04-16
CH59986 1986-02-14

Publications (3)

Publication Number Publication Date
NO861474L true NO861474L (no) 1986-10-17
NO164020B NO164020B (no) 1990-05-14
NO164020C NO164020C (no) 1990-08-22

Family

ID=25685078

Family Applications (1)

Application Number Title Priority Date Filing Date
NO861474A NO164020C (no) 1985-04-16 1986-04-15 Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.

Country Status (16)

Country Link
US (1) US5017619A (no)
EP (1) EP0198412B1 (no)
AR (1) AR242019A1 (no)
AT (1) ATE41655T1 (no)
AU (1) AU592557B2 (no)
DE (1) DE3662521D1 (no)
DK (1) DK163486A (no)
ES (2) ES8802132A1 (no)
FI (1) FI84170C (no)
HU (1) HU200161B (no)
IL (1) IL78475A0 (no)
MC (1) MC1744A1 (no)
NO (1) NO164020C (no)
NZ (1) NZ215753A (no)
PH (1) PH22941A (no)
PT (1) PT82399B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA868891B (en) * 1985-11-27 1988-07-27 Lilly Co Eli Use of phenethanol amines to improve fat content of sow's milk
JPH0761992B2 (ja) * 1987-02-06 1995-07-05 武田薬品工業株式会社 置換アミン誘導体
CA2010638A1 (en) * 1989-03-07 1990-09-07 Leo Alig Bisphenethanolamines
US5451677A (en) * 1993-02-09 1995-09-19 Merck & Co., Inc. Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
GB9308178D0 (en) * 1993-04-21 1993-06-02 Smithkline Beecham Plc Novel compounds
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5541197A (en) * 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5705515A (en) * 1994-04-26 1998-01-06 Merck & Co., Inc. Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
US6043253A (en) * 1998-03-03 2000-03-28 Merck & Co., Inc. Fused piperidine substituted arylsulfonamides as β3-agonists
GB0324654D0 (en) * 2003-10-22 2003-11-26 Glaxo Group Ltd Medicinal compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL108640C (no) * 1958-05-07
NL302260A (no) * 1963-01-24 1900-01-01
GB1109924A (en) * 1965-11-29 1968-04-18 Roche Products Ltd Novel substituted diphenylalkyl amines and a process for the manufacture thereof
US3553266A (en) * 1968-08-08 1971-01-05 American Home Prod Diaralkylamine derivatives
US3577462A (en) * 1968-08-08 1971-05-04 American Home Prod N-arylalkyl-beta-hydroxy-beta-phenyl-ethylamines and the salts thereof
US3706764A (en) * 1969-04-16 1972-12-19 Yoshitomi Pharmaceutical Phenethylaminomethyl-chromanones and- thiochromanones
DE2143204C3 (de) * 1971-08-28 1979-09-27 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt N-Fluoralkyl-phenylisopropylamin-Derivate und deren Salze, Verfahren zu deren Herstellung und Arzneimittel auf deren Basis
EP0021636B1 (en) * 1979-06-16 1982-12-01 Beecham Group Plc Secondary amines, their preparation and use in pharmaceutical compositions
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
EP0118489A1 (en) * 1982-08-27 1984-09-19 Beecham Group Plc Secondary arylethanolamines
GB8415377D0 (en) * 1984-06-15 1984-07-18 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
US5017619A (en) 1991-05-21
ES553974A0 (es) 1988-04-16
DK163486A (da) 1986-10-17
PT82399A (en) 1986-05-01
FI84170C (fi) 1991-10-25
IL78475A0 (en) 1986-08-31
DK163486D0 (da) 1986-04-10
MC1744A1 (fr) 1987-02-26
FI84170B (fi) 1991-07-15
FI861590A0 (fi) 1986-04-15
NZ215753A (en) 1989-10-27
ES8802132A1 (es) 1988-04-16
EP0198412B1 (de) 1989-03-22
AU5579186A (en) 1986-10-23
PT82399B (pt) 1988-08-17
AU592557B2 (en) 1990-01-18
ATE41655T1 (de) 1989-04-15
PH22941A (en) 1989-02-03
HUT42054A (en) 1987-06-29
DE3662521D1 (de) 1989-04-27
EP0198412A1 (de) 1986-10-22
AR242019A1 (es) 1993-02-26
ES8801894A1 (es) 1988-03-01
NO164020C (no) 1990-08-22
FI861590A (fi) 1986-10-17
ES557291A0 (es) 1988-03-01
HU200161B (en) 1990-04-28
NO164020B (no) 1990-05-14

Similar Documents

Publication Publication Date Title
NO852124L (no) Fremgangsmaate ved fremstilling av kinolonderivater.
NO885106D0 (no) FremgangsmŸte ved fremstilling av cytidin-derivater.
NO874764D0 (no) Fremgangsmaate for fremstilling av 2-aminopurinderivater.
NO852994L (no) Fremgangsmaate ved fremstilling av glutaramidderivater.
NO865013D0 (no) Fremgangsmaate for fremstilling av antibaktercelle kinolon-derivater.
NO862861D0 (no) Fremgangsmaate for fremstilling av distamycinderivater.
NO880068L (no) Fremgangsmaate ved fremstilling av heteroaryl-3-okso-propannitrilderivater.
NO165755C (no) Fremgangsmaate ved fremstilling av tetrafluorbenzosyre.
NO855356L (no) Fremgangsmaate ved fremstilling av cefem-derivater.
NO864782D0 (no) Fremgangsmaate ved fremstilling av kinolon-derivater.
NO863251D0 (no) Fremgangsmaate for fremstilling av sphingosinderivater.
NO861474L (no) Fremgangsmaate ved fremstilling av fenetanolaminderivater.
NO852810L (no) Fremgangsmaate ved fremstilling av fluorallylaminderivater.
NO165676C (no) Fremgangsmaate ved fremstilling av pyrrolidonderivater.
NO164030C (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater.
NO166931C (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO860429L (no) Fremgangsmaate for fremstilling av imidazolyl-indol-derivater.
NO854655L (no) Fremgangsmaate ved fremstilling av flavolignanderivateer.
NO851758L (no) Fremgangsmaate ved fremstilling av isokinolinderivater
NO862233D0 (no) Fremgangsmaate ved fremstilling av imidazoquinazolinderivater.
NO851638L (no) Fremgangsmaate ved fremstilling av iminothiazolidin-derivater
NO864525D0 (no) Fremgangsmaate ved fremstilling av aryleddiksyrederivater.
NO861239L (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO166710C (no) Fremgangsmaate ved fremstilling av uretaner.
NO881055D0 (no) Fremgangsmaate ved fremstilling av okso-isoindolinyl-derivater.